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Tbx1 is required for ear development in humans and mice. Gene manipulation in the mouse has discovered multiple consequences of loss of
function on early development of the inner ear, some of which are attributable to a cell autonomous role in maintaining cell proliferation of
epithelial progenitors of the cochlear and vestibular apparata. However, ablation of the mesodermal domain of the gene also results in severe but
more restricted abnormalities. Here we show that Tbx1 has a dynamic expression during late development of the ear, in particular, is expressed in
the sensory epithelium of the vestibular organs but not of the cochlea. Vice versa, it is expressed in the condensed mesenchyme that surrounds the
cochlea but not in the one that surrounds the vestibule. Loss of Tbx1 in the mesoderm disrupts this peri-cochlear capsule by strongly reducing the
proliferation of mesenchymal cells. The organogenesis of the cochlea, which normally occurs inside the capsule, was dramatically affected in
terms of growth of the organ, as well as proliferation, differentiation and survival of its epithelial cells. This model provides a striking
demonstration of the essential role played by the periotic mesenchyme in the organogenesis of the cochlea.
© 2007 Elsevier Inc. All rights reserved.Keywords: Inner ear development; Periotic mesoderm; Tbx1; Mouse genetics; Conditional metationIntroduction
Mammalian inner ear is composed of membranous
labyrinth and bony labyrinth (capsule). The membranous
labyrinth includes the cochlea, the saccule and utricle, the
semicircular canals and the endolymphatic duct. Embedded in
the epithelial structures are 6 sensory organs: the organ of
Corti, which extends along the cochlear duct and is responsible
for sensing sound; the 2 maculae associated with the saccule
and utricle, which reside in the morphological center of the
membranous labyrinth and perceive angular and linear move-
ment; and the 3 balance-sensing cristae at the base of the 3
semicircular canals. The major cell types of the sensory organs⁎ Corresponding author. Institute of Biosciences and Technology, Texas A&M
Health Science Center, 2121 W. Holcombe Blvd., Houston, TX 77030, USA.
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doi:10.1016/j.ydbio.2007.08.006include hair cells, which transfer mechanic deflection into
electric signals, which are forwarded to associated neurons.
Underneath the hair cells in each sensory organ are supporting
cells. The membranous labyrinth is surrounded by a bony
capsule that provides support and protection to the membra-
nous labyrinth. The membranous labyrinth originates from
ectoderm. In the mouse, the otic ectoderm thickens to form the
otic placode, the first recognizable inner ear primordium, at
embryonic day (E) 8. The otic placode invaginates and
becomes the otic pit, which enlarges and closes off from the
ectoderm to form the otocyst. The otocyst undergoes a series
of morphogenetic changes and eventually gives rise to the
complex structures of the membranous labyrinth. The otic
epithelial cells lining the membranous labyrinth proliferate,
migrate and go through fate specification to give rise to the
various types of cells exerting distinct functions (reviewed by
Fekete and Wu, 2002). The mesodermally derived periotic
mesenchyme grows in parallel to the membranous counterpart,
condenses, undergoes chondrogenesis, and eventually gives
rise to the cartilaginous otic capsule. During the morphogen-
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surrounding capsule. In particular, the periotic mesenchyme
provides inductive signal for the formation of the otic placode
at an early stage (reviewed by Barald and Kelley, 2004), and
otic epithelium sends out cues, including FGF and TGFβ/BMP
signals, toward the periotic mesenchyme to regulate capsule
chondrogenesis (Frenz et al., 1994; Liu et al., 2003). However,
the evidence for a role of periotic mesenchyme/capsule in the
morphogenesis of the membranous labyrinth is limited to
tissue culture or explant data (Doetzlhofer et al., 2004;
Montcouquiol and Kelley, 2003). In addition, gene knock-out
experiments suggest that genes expressed in the periotic
mesenchyme may be critical for the morphogenesis of
membranous labyrinth, albeit no effect on inner hair cell
development could be demonstrated (Phippard et al., 1999;
Pirvola et al., 2004).
Tbx1 encodes a transcription factor containing a conserved
DNA-binding T-box domain. Haploinsufficiency of TBX1 has
been associated with Del22q11 syndrome, a disorder mostly
caused by a segmental deletion of chromosome 22q11.2
(del22q11.2) that includes TBX1 (Jerome and Papaioannou,
2001; Lindsay et al., 2001; Merscher et al., 2001). Most
Del22q11 syndrome patients, and one patient with TBX1
mutation, have hearing impairment, sometimes of sensorineural
type (Digilio et al., 1999; Reyes et al., 1999; Swillen et al.,
1999; Yagi et al., 2003). Tbx1 is expressed in a subregion of the
otocyst and in the periotic mesenchyme (Raft et al., 2004;
Vitelli et al., 2003). However, the detailed expression profile of
Tbx1 in late development of the inner ear has not been studied.
In Tbx1−/− animals, the otocyst is small and the sensory organs
do not form (Moraes et al., 2005; Raft et al., 2004; Vitelli et al.,
2003). Tbx1 is required for contribution, proliferation and fate
determination of a subset of otic epithelial cells (Moraes et al.,
2005; Raft et al., 2004; Vitelli et al., 2003; Xu et al., 2007).
Tissue-specific ablation revealed that Tbx1 expression in the
otic epithelium is required for the development of both
vestibular and auditory system (Arnold et al., 2006; Xu et al.,
2007), while its ablation in the mesoderm causes yet to be
defined cochlear abnormalities (Xu et al., 2007). To gain further
insight into the function of Tbx1 during inner ear morphogen-
esis, we examined Tbx1 expression in the inner ear at post-
otocyst stages and characterized the malformations caused by
mesodermal ablation of Tbx1. We found that Tbx1 is
persistently and broadly expressed in the non-sensory epithelial
structures of the inner ear, while its expression in sensory
organs is restricted to the vestibule. In the periotic mesench-
yme, its expression is restricted to the pericochlear region. WeFig. 1. Tbx1 expression in the developing inner ear of Tbx1+/lacZ embryos/fetuses. (
derived β-gal activity. The embryos/head tissues in B–G were cleared. (A′–C′) hi
sections of an X-gal-stained E18.5 inner ear. H: Tbx1 is expressed in the epithelium o
area is magnified in panel H′. (I) Tbx1 is expressed in the hair cells (HC) and the sup
canal. (J) Tbx1 is expressed in the non-sensory epithelium of the saccule (S) and utri
Boxed areas magnified in panels J′1 and J′2. (K) Tbx1 is expressed in subsets of non-se
POM, periotic mesenchyme; Ot, otocyst; Co, cochlear; ssc, lsc and psc, superior, later
media; ST, scala tympani; SV, scala vestibuli; OHC, outer hair cell; IHC, inner hair ce
C, F and G; 50 μm in panels C′, H–K; 20 μm in H′, I′, J′2 and K′; 10 μm in panelshow that mesodermal Tbx1 is required for the formation of the
pericochlear capsule, which, in turn, is essential for cochlear
development.
Materials and methods
Mouse mutants
All the experiments involving mice were done according to a protocol
reviewed and approved by the Institutional Animal Care and Use Committee of
Institute of Biosciences and Technology, in compliance with the USA Public
Health Service Policy on Humane Care and Use of Laboratory Animals. The
following mouse mutant lines have been described previously: TgCAGG-
CreERTM (Hayashi and McMahon, 2002), Tbx1flox/flox (Xu et al., 2005, 2004),
Tbx1+/lacZ (Lindsay et al., 2001) andMesp1Cre/+ (Saga et al., 1996).Mesp1 is an
early mesodermal marker expressed in epiblast cells sorting through the
primitive streak before E7, i.e. before Tbx1 is turned on, and then is rapidly
down-regulated (Saga et al., 1996; Zhang et al., 2005).
All lines were backcrossed into the C57Bl6 genetic background for at least 2
generations. Mice were genotyped using PCR as described in the original
reports. To induce nuclear translocation of the inducible Cre encoded by the
TgCAGG-CreERTM transgene, pregnant mice were treated with single
intraperitoneal injection of Tamoxifen (Sigma) at a dose of 75 mg/kg body
weight on embryonic day (E) 8.5. Tamoxifen was prepared as described before
(Xu et al., 2005).Histology, X-gal staining, and immunohistochemistry
To collect head tissue containing the inner ear from embryos or fetuses
older than E13.5, we bisected the head and removed excess tissue around the
ear. To visualize β-gal activity, we stained paraformaldehyde-fixed embryos/
head tissue using the X-gal substrate, according to standard procedures. To
clear embryos, we fixed and dehydrated them in ethanol/water/acetic acid/
chloroform (95:3:1:1) solution and then treated with methyl salicylate/benzyl
benzoate (50:50) solution. Stained embryos were photographed as whole
mounts and then embedded in paraffin and cut in 10-μm histological sections.
The relative length of the cochlear duct was calculated as Lr =Lm/Lc, where Lr,
Lm and Lc are the relative length of a mutant cochlear duct, the actual length
of the mutant cochlear duct, and the average actual length of the control
cochlear ducts, respectively. Lm and Lc can be calculated as the length of the
imaged cochlear ducts, as measured with Photoshop software, divided by cos
(α), where α is the descending angle of the cochlear ducts, presumably the
same among the cochlear ducts. Sections were counterstained with Nuclear
Fast Red. 3-Dimensional reconstruction was performed with WinSURF
software. Immunohistochemistry on paraffin sections was performed following
the protocols accompanying the antibodies or as described before (Xu et al.,
2005, 2004). The following antibodies were used for immunohistochemistry or
immunofluorescence: rabbit anti-phospho-Histone H3 (Ser10) (Upstate
Biotechnology; 1:100), rabbit anti-myosin 7a (ab3481) (Abcam; 1:500), rabbit
anti-human P27Kip1 (Lab Vision; 1:100), mouse anti-Islet1, clone 2D6
(Developmental Studies Hybridoma Bank; 1:200) and rabbit anti-cleaved
caspase 3 (Cell Signaling Technology). The mitotic index was calculated as
percentage of P-H3+ cells over the total of cells counted (at least 2600 cells
per cochlea).A–G) X-gal-stained embryos (A–C) or head tissues (D–G) showing Tbx1lacZ-
stological sections of the embryos shown in panels A–C. (H–K) Histological
f the semicircular canals, but not in the capsule surrounding the canals; the boxed
porting cells (SC) of the crista (magnified in panel I′) in a posterior semicircular
cle (U), but not the hair cells (HC) and the supporting cells (SC) of the maculae.
nsory epithelium lining the scala media (SM), but not in the organ of Corti (OC).
al and posterior semicircular canal, respectively; S, saccule; U, utricle; SM, scala
ll; VM, vestibular membrane; StV, stria vascularis. Scale bars: 500 μm in panels
K″1.
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RNA in situ hybridization experiments with radioactive probes were
performed on tissue sections according to published protocols (Albrecht et al.,
1997). Labeled probes were prepared by reverse transcription of DNA clones in
the presence of 35S-UTP (ICN).Results
Tbx1 is expressed dynamically during inner ear organogenesis
At E10.5, Tbx1 is expressed in most of the mouse otic
epithelium, including the compartments that will give rise to the
vestibular system and the cochlea (Raft et al., 2004; Vitelli et al.,
2003). The neurogenic area and the primitive endolymphatic
duct and sac do not express Tbx1. Tbx1 is also expressed in the
periotic mesenchyme. However, the expression of Tbx1 at later
stages during the organogenesis of the inner ear has not been
described in detail. Therefore, we have collected Tbx1lacz/+
embryos between E10.5 and E18.5 and performed X-gal
staining to reveal the expression of the gene as visualized by
β-galactosidase (β-gal) activity (Vitelli et al., 2002).
In contrast to early developmental stages, we found
differential expression in the vestibular and cochlear territories.
Specifically, in the semicircular canals, Tbx1 was expressed in
the non-sensory epithelium throughout morphogenesis (Figs.
1C–G, H, H′) and in the sensory epithelium of the cristae since
their formation at E12.5 (Figs. 1C–G, I, I′). At E18.5, Tbx1 was
still expressed in the hair cells and the supporting cells of the
cristae (Figs. 1I, I′). In the saccule and the utricle, Tbx1 was
found in the non-sensory epithelium (Figs. 1E–G, J, J1′, J2′), but
not in the maculae (Figs. 1J, J1′, J2′ and data not shown). At
E18.5, neither the hair cells nor the supporting cells of the
maculae expressed Tbx1 (Figs. 1J, J1′, J2′). In the developing
cochlear duct, Tbx1 expression was restricted to the non-
sensory compartment (Figs. 1B′, C′, K, K′ and data not shown).
This differential expression pattern was evident as early as
E11.5 (Figs. 1B′, C′). At E18.5 Tbx1 expression was detected in
the vestibular membrane (Figs. 1K′, K2″) and in the stria
vascularis (Figs. 1K′, K3″), while cells of the organ of Corti,
including hair cells and supporting cells, were negative (Figs.
1K′, K1″). The mesenchyme surrounding the developing
membranous labyrinth starts to condense at E12.5, and
eventually gives rise to the capsule of the inner ear. We found
that Tbx1 is differentially expressed also within the surrounding
mesenchyme/capsule as the one surrounding the cochlea
expressed Tbx1 throughout inner ear organogenesis (Figs.
1A–G, K), while the one surrounding the vestibular system did
not (Figs. 1A–H, J).
Tbx1 controls cochlear capsule morphogenesis and cochlear
organogenesis
The differential expression of Tbx1 in the periotic mesench-
yme poses the intriguing question of whether the gene plays a
direct role in “building” the pericochlear capsule and, by doing
so, supports the adjacent membranous labyrinth. Indeed,mesodermal ablation of Tbx1 affects cochlear development
(Xu et al., 2007). However, the role of Tbx1 in the periotic
mesenchyme has not been addressed in details. Therefore, we
examined the inner ear of Mesp1Cre/+;Tbx1flox/laZ (hereafter
referred to as M-ko) mutants, in which Tbx1 is homozygously
deleted in the mesoderm (Xu et al., 2007). This Cre driver
induces recombination in the cranial mesoderm but not in the
otic epithelium (Supplementary Fig. 1A).
Because Tbx1lacZ-derived β-gal activity outlines most inner
ear structures, we were able to detect gross morphological
defects by examining X-gal-stained whole mount inner ear
preparations. At E11.5, the M-ko inner ear was indistinguish-
able from controls (data not shown). In E12.5 mutants, the
cochlear duct was shorter than that in the controls (69±0.3%,
mean±S.D., mutant versus control, n=4). At E13.5, the mutant
cochlear duct remained shorter than in controls (48±0.2%,
mean±S.D., mutant versus control, n=4), and did not undergo
spiral looping (Figs. 2A, A′, C, C′). By E16.5, the control
cochleae had completed almost 2 turns (Figs. 2B, B′), but the
mutant cochleae remained short and uncoiled. In addition, the
overall size of the inner ear appeared reduced (Figs. 2D, D′). In
the control embryos, we observed strong β-gal activity in the
mesenchyme surrounding the developing cochlea, while it was
very low or undetectable in M-ko embryos at E10.5–E13.5
(Fig. 2C′ and data not shown), possibly due to loss of tissue or
suppression of gene expression. At E16.5, the control cochlea
was enclosed in a cartilaginous capsule that was mostly β-gal-
positive (Figs. 2B, B′). In contrast, the cochlea in the mutant
was only partially surrounded by the capsule, which was widely
open in the medial side facing the brain and it was β-gal positive
only in the most ventral portion (Figs. 2D, D′).
Three-dimensional reconstruction confirmed the morpholo-
gical defects of the capsule and cochlea of M-ko mutants at
E16.5 (Figs. 2Bʺ, Dʺ). The vestibular system appeared normal
in most (8 out of 12) mutants, although we could detect thinning
or truncation in some (4 out of 12) semicircular canals (Fig.
2D). Cochlear hypoplasia was variable, although in most
(11/12) M-ko embryos the cochlea was rudimentary, with only a
small portion recognizable as cochlear duct (Fig. 2D). In only 1
out of the 12 M-ko embryos examined, no cochlear structure
could be recognized morphologically. Defects found at E18.5
were similar to those described above (Figs. 3A, A′, B, B′). In
summary, M-ko embryos have early, severe abnormalities of the
mesoderm-derived periotic mesenchyme and capsule surround-
ing the cochlea. In this context, the cochlea, which is not of
mesodermal derivation, developed normally until E11.5–E12.5
but stopped growing thereafter.
Mesodermal Tbx1 expression is required for the development
of hair cells and supporting cells in the apical and medial parts
of the cochlea
The data reported above suggest that mesodermal ablation
of Tbx1 approximates a physical removal of a large portion of
the pericochlear capsule in vivo. To understand better the
nature of the cochlear phenotype, we examined in greater detail
the organ of Corti (OC), the sensory organ of the cochlea. The
Fig. 2. Morphological defects in M-ko mutant inner ear. (A–B) Normal morphology of inner ear at E13.5 (A, A′) and at E16.5 (B, B′ and B″), respectively. Panels A′
and B′ are sections of the samples shown in panels A and B, respectively. Panel B″ is the 3-D reconstruction of the cochlear duct (red) and pericochlear capsule (green)
shown in panel B. For the pericochlear capsule, only the portion with β-gal activity was reconstructed. (C–D) abnormal morphology of M-ko mutant inner ear. The
cochlea (highlighted in red) is hypoplastic and the lateral semicircular canal suffers a regional thinning (arrow in D). The cochlear duct at E16.5 (D) is only modestly
longer than at E13.5 (B), and fails to undergo spiral looping. There is severe loss of Tbx1-expressing mesenchyme/capsule surrounding the cochlear duct, which is
evident in the sections (C′ and D′) and most appreciable in the 3-D reconstruction (D″, green). Scale bars: 500 μm in C and D; 100 μm in panels C′ and D′.
333H. Xu et al. / Developmental Biology 310 (2007) 329–340OC is a specialized region of the epithelium lining the scala
media (Figs. 1K′, K1″, 3E, G). In M-ko mutants, we could not
identify an OC using histological analysis (Figs. 3F, H). The
major cell types of the OC are mechanosensory hair cells and
supporting cells. We performed immunofluorescence on
sections of E18.5 inner ears using antibodies against Myosin
7a and P27Kip1, which label hair cells and supporting cells,
respectively (Hasson et al., 1995; White et al., 2006). Hair cells
and supporting cells were readily detected in control OC
throughout the cochlear duct (Figs. 3C, E, G). In M-ko
cochleae, despite the lack of any morphological structure
resembling the OC, we could identify a few hair cells but only
in the basal portion of the duct (Fig. 3D), no hair cells or
supporting cells could be detected in the rest of the mutant
cochlea (Figs. 3F, H). These results indicate a profound effect
of the loss of mesodermal Tbx1 on cochlear development.
Indeed, this is not limited to growth failure but extends to cell
differentiation and general organ architecture. We have
examined hair and supporting cell differentiation in the cristae
of M-ko mutants and found it apparently normal. This is
consistent with the finding that Tbx1 is normally expressed in
these cells and not in the surrounding mesenchyme, thus
deletion of the gene in the mesoderm should not change the
environment within which the crista develops.
The next question is whether the M-ko cochlear phenotype is
caused by the loss of transcriptional activity of Tbx1 or by the
loss of capsular tissue (or both). While this is a difficult question
to address, we reasoned that if we eliminate the Tbx1 gene after
the capsule is formed, we should at least be able to understandwhether Tbx1 directly activates signals required to support
cochlear growth and sensory cell differentiation. To this end, we
have used an inducible Cre–loxP system, as reported previously
(Xu et al., 2005). TgCAGG-CreERTM transgenic mice express
ubiquitously a Tamoxifen (TM)-inducible Cre (Hayashi and
McMahon, 2002). With this system, we obtained depletion of
the Tbx1 protein after 24 h from TM injection (Supplementary
Fig. 1B–C and Xu et al., 2005).
We crossed TgCAGG-CreERTM;Tbx1+/lacZ males with
Tbx1flox/flox females and injected a single dose of TM to
pregnant females at E10.5 and E11.5, and examined the fetuses
at E18.5. TM injections at these stages should eliminate the
gene approximately at E11.5 and E12.5, respectively (Xu et al.,
2005), i.e. immediately before the onset of the cochlear
phenotype in M-ko mutants, but later than the onset of the
mesodermal phenotype. The development of the inner ear was
severely disrupted in fetuses exposed to TM at E10.5, the
semicircular canals and the associated cristae failed to form
(Fig. 4A), the saccule and utricle were recognizable, but smaller
than in controls (data not shown). The capsule surrounding the
cochlea was also smaller (Fig. 4A, compare to Fig. 3A),
although the reduction in size was not so pronounced as in
Mesp1Cre/+;Tbx1flox/− mutants (Fig. 4A, compare to Fig. 3B).
The isolated “cochlea” from the timed mutants exposed to TM
at E10.5 had a sac-and-stem shape, instead of the characteristic
spiral coil shape (Fig. 4A′, compare to Fig. 3A′). Histological
sections confirmed the morphological defects of timed mutants
(Fig. 4C), and, in addition, we could not identify an organ of
Corti (Fig. 4C). Immunofluorescence with an anti-myosin 7a
Fig. 3. Lack of hair cell and supporting cell differentiation in M-ko mutant cochlea at E18.5. (A–B) Gross morphology of a control (Tbx1+/lacZ, A) and an M-ko mutant
(B) inner ear. Panels A′ and B′ are isolated cochlea from a control and a mutant inner ear, respectively. The vestibular system of the mutant inner ear is essentially
normal, but the cochlea and pericochlear capsule is hypoplastic (B, B′). (C–F) Immunofluorescence with an antibody against Myosin 7a to reveal differentiated hair
cells. While hair cells are readily detected in the basal (C) and medial (E) portions of the control cochlea, only the basal portion contain hair cells (D) and no hair cell
can be detected in the medial or apical portion (F) of the mutant cochlea. (G–H) Immunofluorescence with an antibody against P27Kip1 to reveal differentiated
supporting cells. While supporting cells are readily detected in the medial portion of the control cochlea (G), they cannot be detected in the mutant cochlea (H). Scale
bars: 500 μm in B; 50 μm in panel H.
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“cochlea”, but the hair cells only existed in the medial–posterior
portions of the sac in a cluster with 6–7 cells visible on each
section (Fig. 4E). We also performed a late time point deletion
(TM at E14.5) and examined cochleae at E18.5. As expected,
the cochleae appeared normal in these mutants, although the
semicircular canals were still sensitive to late loss of Tbx1 and
were hypoplastic (data not shown).
Overall, the timed mutant phenotype was more complex than
in M-ko mutants, most likely because timed-ablation eliminated
Tbx1 from both the otic epithelium and the mesoderm.Nevertheless, the cochlear phenotype, though severe, is dif-
ferent, and even less severe as far as cochlear hair cell dif-
ferentiation is concerned. Tbx1 is required in the otic epithelium
for cell proliferation and, to a lesser extent, for cell survival (Xu
et al., 2007), therefore, it is predictable that timed deletion
would disrupt the epithelial component of the inner ear. Because
Tbx1 is switched off in cochlear hair cells approximately at
E11.5, TM injection at E10.5 should hit the “tail” of Tbx1
expression in those cells, hence the presence of a portion of hair
cells in the timed mutants. In contrast, the non-sensory
components of the cochlea continue to express Tbx1 well
Fig. 4. Inner ear phenotype in Tbx1 timed mutants at E18.5. (A–B) Gross morphology of the inner ears from two timed mutants exposed to Tamoxifen (TM) at E10.5
(A) and E11.5 (B), respectively. Panels A′ and B′ are isolated cochlea. (C–D) Histological sections of cochleae of timed mutants exposed to TM at E10.5 (C) and E11.5
(D), respectively. (E–F) Immunofluorescence with an antibody against myosin 7a to reveal hair cells. The location of the sections in the inner ear equivalent to the
boxed areas in panels C and D, respectively. Scale bars: 500 μm in panel B; 100 μm in panel D; 50 μm in panel F.
335H. Xu et al. / Developmental Biology 310 (2007) 329–340after E11.5, thus explaining the severe phenotype of the non-
sensory epithelium. However, injection at E11.5 should
definitely not affect Tbx1 expression in progenitors of cochlear
hair cells. Indeed, although the overall size of timed mutants
with TM injection at E11.5 was smaller (Fig. 4B), and the
semicircular canals were clearly thinner than in control fetuses
(Fig. 4B, compare to Fig. 3A), the cochleae were normally
coiled, the OC was formed and included differentiated, well-
patterned hair cells (Figs. 4B–F). Thus, timed deletion
experiments suggest that at least a large component of the M-
ko cochlear phenotype is secondary to loss of capsule tissue
rather than to loss of Tbx1-triggered signals from the capsule to
the cochlea.The pro-sensory patch is specified in M-ko mutants
Next, we asked whether the loss of hair and supporting cells
in the M-ko mutant cochleae was due to failed specification of
the pro-sensory patch, which contains progenitors of hair cells
and supporting cells. We performed immunohistochemistry
using an antibody against Islet 1 (Isl1), which is expressed in the
pro-sensory patch of the cochlea (Radde-Gallwitz et al., 2004).
In both control and mutant cochlear ducts at E13.5, Isl1 was
expressed exclusively in the pro-sensory epithelium that was
thickened and negative for Tbx1 expression, although the
mutant cochlear duct was shorter and less coiled (Figs. 5A1–
B2). BMP4 and Fgf10 identify individual subsets of cells of the
Fig. 5. Specification of the prosensory patch in the developing cochlea of M-ko mutants. (A1–B2) Immunohistochemistry with an antibody against Isl1 on sections
from X-gal-stained embryos. The sections with subscript number “2” is more anterior, therefore the cochlear portions are more basal than “1”. (C1–F2) RNA in situ
hybridization with 35S-labeled probes of Bmp4 (C1–D2) and Fgf10 (E1–F2). The sections with subscript number “2” is more anterior, therefore the cochlear portions
are more basal than “1”. (G1–H3) Immunofluorescence with an antibody against P27
Kip1 to reveal the nonproliferation zone (NPZ, lower domain in panels G1–G3 and
H1–H2) in the cochlea. Scale bars: 50 μm.
336 H. Xu et al. / Developmental Biology 310 (2007) 329–340developing cochlear duct (Morsli et al., 1998; Pauley et al.,
2003). In situ hybridization revealed that these twomarkers were
normally expressed inM-ko mutants (Figs. 5C–F). Hair cell and
supporting cell progenitors of the pro-sensory patch of the
cochlea exit the cell cycle at around E13.5 (Ruben, 1967). This
process is associated with expression of the cell cycle inhibitor
P27Kip1, which marks the non-proliferation zone (NPZ) (Chen
and Segil, 1999; Lowenheim et al., 1999). We used immuno-
fluorescence to examine the expression of P27Kip1 in E14.5
embryos. Results revealed the existence of NPZ in the mutant
cochlear duct (Figs. 5G1–H3). However, this region was slightly
broader in the middle portion and the apex of the mutant
cochleae (Figs. 5H2, H3). Overall, these data suggest that the pro-sensory patch is properly specified in M-ko embryos, despite the
shortened cochlear duct. Because we did not see expansion of
the pro-sensory patch with other markers, the broader P27Kip1
positivity in the middle and apical portions of the mutant
cochleae may be due to a larger number of cells exiting the cell
cycle for reasons other than increased number of progenitors.
The periotic mesenchyme regulates proliferation and survival
of the cochlear epithelium
To follow up the results obtained with the P27Kip1 marker, we
tested cell proliferation and survival in theM-ko cochlea.We used
anti-phospho-H3 immunohistochemistry to evaluate the mitotic
337H. Xu et al. / Developmental Biology 310 (2007) 329–340index. Because cochlear hypoplasiawas evident fromE12.5 inM-
ko embryos, we tested this stage for cell proliferation. We found
that themitotic index of cochlear epithelial cells of the pro-sensory
compartment was lower in mutants than in controls (Fig. 6)
(p=0.023, n=3, t-test), and there was no significant difference in
the non-sensory compartment (p=0.054, n=3, t-test). Interest-
ingly, only the apical and middle portions of the pro-sensory
compartment were affected, while the basal portion exhibited
normal cell proliferation. This is consistent with the existence of
hair cells in the basal cochlea at E18.5. Next, we asked whether
mesenchymal cells may have a reduced mitotic index. Indeed,
results showed a strong reduction in cell proliferation activity in
M-ko embryos (Fig. 6C) (p=0.002, n=3, t-test).
We also examined apoptosis in the epithelium of the devel-
oping cochlea. An antibody anti-cleaved Caspase 3 (cCasp3)
was used as an apoptotic marker in E12.5 to E17.5 embryos. At
E12.5, regional apoptosis was readily detected in the basalFig. 6. Impaired cell proliferation in the cochlear duct and pericochlear mesenchyme
Boxed areas are magnified in panels A′ and B′. The cochlear duct is grossly divide
regional change in cell proliferation in M-ko mutant. (C) Quantitation of cell proliferat
significant difference (**pb0.01, Student's t-test). Scale bars: 100 μm in panel B acochlea of control embryos (Figs. 7A, A′) along with other
apoptotic areas in the inner ear, as previously described (Nikolic
et al., 2000). Apoptosis was increased in the basal cochlea of
mutant embryos (approx. twice as many cCasp3+ cells), while it
appeared unchanged elsewhere (Figs. 7B, B′). At E16.5, control
embryos presented apoptosis in a subset of cells of the non-
sensory compartment, probably the prospective osseous spiral
lamina (Figs. 7C, C′), and predominantly in the middle and
basal turns, as previously reported (Nikolic et al., 2000). In
contrast, in M-ko cochleae, apoptosis was expanded in the
apical portion, which contained ectopic apoptotic cells (Figs.
7D, D′). Overall, control cochleae had 240±2 apoptotic cells,
while M-ko cochleae had 497±5 apoptotic cells. Such an
expanded apoptotic pattern in the mutant cochlea was
appreciable as early as E15.5, and remained apparent as late
as E17.5 (the latest stage tested, data not shown). These data
suggest that augmented apoptosis, especially at later stages,at E12.5. (A–B) Immunohistochemistry using an antibody against phospho-H3.
d into apical (Ap), medial (Me) and basal (Ba) portions to detect the potential
ion. Asterisks indicate significant difference (*pb0.05, Student's t-test) and very
nd 50 μm in panel B′.
Fig. 7. Reduced cell survival in the cochlear duct of E12.5 and E16.5 embryos. (A–B) Increased apoptosis (arrows) in the basal portion of an M-ko mutant cochlea at
E12.5. Boxed areas magnified in panels A′ and B′. (C–D) Ectopic apoptosis (arrowheads) in the apical portion of an M-ko mutant cochlea at E16.5. Boxed areas
magnified in panels C′ and D′. Scale bars: 100 μm in panel D; 10 μm in panel B′ and 50 μm in panel D′.
338 H. Xu et al. / Developmental Biology 310 (2007) 329–340may play a role in the hypoplasia of the mutant cochlea, while
reduced proliferation appears to be the primary event.
Discussion
Tbx1 expression distinguishes different populations of hair/
supporting cells
Our results indicate that Tbx1 is expressed in the mature hair
cells and supporting cells in the cristae, but not in the other
sensory organs. To our knowledge, there are no other genes
known to distinguish hair/supporting cells in different sensory
organs. Thus, although Tbx1 is expressed in progenitors of all
the hair/supporting cells of the inner ear at E10.5, its expression
is suppressed in a subpopulation of progenitors destined to the
cochlea at around E12.5. Interestingly, the vestibular hair cells
have regenerative capacity, albeit limited, while the cochlear
hair cells do not (Forge et al., 1993; Warchol et al., 1993). Given
its developmental role in regulating/maintaining cell prolifera-
tion in several tissues (Xu and Baldini, 2007), including the
inner ear (this work), Tbx1 represents an exciting new candidate
factor conferring regenerative capacity to vestibular hair cells.
Tbx1 ablation in the mesoderm results in partial loss of the
pericochlear capsule
Tbx1 is expressed in the periotic mesenchyme and later in the
pericochlear capsule. It was suggested that Tbx1 is involved in
initiation of chondrogenesis in the periotic mesenchyme
(Riccomagno et al., 2002). We show that ablation of Tbx1 by
theMesp1Cre driver strongly down-regulates the proliferation of
periotic mesenchymal cells in E12.5 embryos. In addition, we
have previously shown that mesodermal proliferation in M-koembryos is reduced as early as E8.5 (Zhang et al., 2006)
supporting a function of Tbx1 in the mesoderm well before the
capsule is formed. At E16.5, the disruptive effect of Tbx1
ablation is manifested by a considerable reduction of the size of
the pericochlear capsule in M-ko mutants. These observations
suggest that Tbx1 regulates the number of cells destined to
undergo chondrogenesis rather than regulate chondrogenesis
directly.
Tbx1 can respond to Sonic hedgehog (Shh) signaling from
the notochord and/or floor plate (Riccomagno et al., 2002). In
agreement with this, the pericochlear mesenchyme/capsule
(closest to the notochord and floor plate) has the strongest
expression of Tbx1 (as evaluated by β-gal activity derived from
the Tbx1lacZ allele), and is most affected by mesodermal
ablation of Tbx1, while the perivestibular mesenchyme/capsule
(distant from the notochord and floor plate) is negative for Tbx1
expression and is not affected by the ablation of Tbx1. In fact,
the M-ko mutant provides a good model where physical
ablation of pericochlear mesenchyme/capsule can be achieved
through a genetic mutation.
Proliferation and survival of cochlear epithelial cells require
pericochlear mesoderm
It has already been reported that the periotic mesenchyme
supports cochlear development (Doetzlhofer et al., 2004;
Montcouquiol and Kelley, 2003). Homozygous deletion of the
periotic mesenchyme-expressed Brn4/Pou3f4 gene caused
middle ear abnormalities and cochlear dysplasia but did not
affect hair cell development (Phippard et al., 1999). Our data
provide the first evidence in vivo of the dramatic role that the
periotic mesenchyme has on the development of the organ of
Corti. The mesoderm not only plays a trophic role required for
339H. Xu et al. / Developmental Biology 310 (2007) 329–340cell proliferation, survival, and organ growth but also for cell
differentiation. The latter impairment may be in part secondary
to proliferation and survival defects, which may create an
inappropriate environment for differentiation. Whether the
phenotype of M-ko mutants is due to loss of mesodermal tissue
or loss of Tbx1-dependent signals (or combination of the two) is
difficult to determine. However, in M-ko mutants, the perico-
chlear mesenchyme/capsule is severely reduced, thus at least
part of the phenotype is likely to derive from loss of tissue. In
addition, timed-deletion experiments suggested that the
cochlear phenotype is due to an early function of Tbx1, thus
unlikely to be due to loss of later function of Tbx1 in the con-
densed mesenchyme that surrounds the developing cochlea.
In conclusion, our data show a critical role of Tbx1 in
maintaining the proliferation of mesodermal cells destined to
build the cartilaginous capsule surrounding the cochlea. In
addition, or perhaps secondary to the role in the formation of the
capsule, mesodermal deletion of Tbx1 affects the formation of
the apical and medial portions of the cochlea by reducing cell
proliferation, survival and differentiation.
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